Treatment Of Depression – Tenil Sat, 18 Sep 2021 13:27:37 +0000 en-US hourly 1 Treatment Of Depression – Tenil 32 32 Zydus Cadila Gets USFDA Approval to Market Depression Drug in United States Sat, 18 Sep 2021 10:54:00 +0000

Pharmaceutical company Zydus Cadila announced on Saturday that it had received approval from the U.S. health regulator to bring vortioxetine tablets, used to treat depression, to the U.S. market.

The company has received final approval from the United States Food and Drug Administration (USFDA) to market Vortioxetine tablets in strengths of 5 mg, 10 mg, 20 mg, Zydus Cadila said in a statement.

Vortioxetine is used to treat depression. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

The drug will be manufactured at the group’s formulation manufacturing plant in the Ahmedabad SEZ, Zydus Cadila noted.

The group now has 322 approvals and has so far filed more than 400 Abbreviated New Drug Applications (ANDAs) since starting the filing process in fiscal year 2003-04, he added. .

(Only the title and image of this report may have been reworked by Business Standard staff; the rest of the content is automatically generated from a syndicated feed.)

Dear reader,

Business Standard has always strived to provide up-to-date information and commentary on developments that matter to you and have broader political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these difficult times resulting from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative views and cutting edge commentary on relevant current issues.
However, we have a demand.

As we fight the economic impact of the pandemic, we need your support even more so that we can continue to provide you with more quality content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscriptions to our online content can only help us achieve the goals of providing you with even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital editor

Source link

]]> 0
Hospitals face urgent need for drug treatment in emergency departments Sat, 18 Sep 2021 04:02:32 +0000

UCSF study shows emergency visits and hospitalizations for drug addicted patients increased by 30% compared to 2014-2018

By Élisabeth Fernandez

A growing percentage of emergency visits and hospitalizations in the United States before the pandemic involved patients with alcohol and other substance disorders, according to a study by researchers at UC San Francisco . The authors say hospitals need to develop better ways to identify and treat these patients.

The study, led by Leslie Suen, MD, MAS, of the UCSF Department of Medicine, found that between 2014 and 2018, emergency room visits by adults with alcohol use disorders and of substances increased by 30%. Hospitalizations among patients with these disorders increased by 57 percent.

The authors found that over the study period, one in 11 emergency room visits and one in nine hospitalizations each year involved someone with an alcohol or other substance disorder.

“These statistics are comparable to common ailments such as heart failure, but hospitals and emergency departments are rarely as equipped to treat drug addiction as they are to treat cardiovascular disease,” said Suen, member of the National Clinician Scholars. UCSF Philip R. Lee Program. Institute for Health Policy Studies.

“These data suggest that there is an urgent need for hospitals to develop inpatient intervention systems to provide drug addiction treatment to those accessing emergency care and inpatients. Models of inpatient drug addiction services already exist, including the UCSF addiction care team at San Francisco General Hospital.

The study was published on September 13, 2021 in the Journal of General Internal Medicine.

Researchers found that patients with alcoholism and other substance use disorders who came to the emergency room were more likely to have Medicaid health insurance, experience depression, be homeless, ” have received mental health treatment and present injuries and trauma.

“Illnesses and deaths from complications of alcohol and other substance use are on the rise nationwide,” Suen noted. “Hospitals are a place where we can start to reverse this trend, but we have to be prepared to identify and treat these patients while they are in hospital and continue to monitor and treat them after discharge as well.”

For the study, researchers analyzed data from the National Hospital Ambulatory Medical Care Survey, an annual survey administered by the National Center for Health Statistics. Alcohol use disorders and other substance use disorders were identified on the basis of patient medical records.

“Our estimate of alcohol and substance use disorders during emergency room visits is higher than in some other recent studies,” Suen said. “This may be because our study is the first to use comprehensive medical chart reviews, which are more likely to reflect the true prevalence of these disorders, rather than relying solely on billing diagnostic codes.”

UCSF co-authors are Leslie Suen, MD, MAS; Anil N. Makam, MD, MAS; Hannah R. Snyder, MD; Daniel Repplinger, MD; Margot B. Kushel, MD; Marlene Martin, MD; and Oanh Kieu Nguyen, MD, MAS. The study was supported by the National Heart, Lung and Blood Institute. The authors declare no conflict of interest.

The University of California at San Francisco (UCSF) focuses exclusively on the health sciences and is dedicated to promoting health around the world through advanced biomedical research, higher education in the sciences of life and health professions and excellence in patient care. UCSF Health, which serves as the primary academic medical center for UCSF, includes leading specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area.

Source link

]]> 0
Kenosha News editorial: These psychedelic experiences at UW are for therapy | Editorial Fri, 17 Sep 2021 12:00:00 +0000

They are experimenting with psychedelic drugs again at UW-Madison.

No, we’re not talking about wide-eyed college students in tie-dyed T-shirts walking along Picnic Point whispering “Oh, Wow” as they do their own “independent research” into spiritualism and religion. self-realization. It was in the 60s.

We’re talking about research, rigorously controlled clinical research, with human trials to see if long-banned drugs like psilocybin (magic mushrooms) can be used to treat depression or addiction. UW researchers are testing MDMA (think the club drug known as ecstasy or molly) to see if it can boost psychotherapy to treat post-traumatic stress disorder.

A new study suggests that psilocybin may be as effective as major antidepressants. According to a study published in the “New England Journal of Medicine”. psilocybin, the active compound in magic mushrooms, may be as effective as selective serotonin reuptake inhibitors. the main type of antidepressant drug. PsyPost reports that 59 men and women with moderate to severe depression participated in the 6-week trial. . Psilocybin therapy appears to be at least as effective as a leading conventional antidepressant and works faster with a reassuring safety profile when administered by professional therapists, study author Robin Carhart-Harris and head of the Center for Psychedelic Research at Imperial College London, via PsyPost. Patients in the psilocybin group would have been less likely to have side effects such as anxiety, dry mouth, sexual dysfunction, and reduced emotional reactivity. Researchers involved in the study noted that although the results are intriguing. a larger and longer study would be necessary to arrive at conclusive results.

As editor-in-chief Preston Schmitt reported in the current issue of “On Wisconsin,” the UW alumni magazine, the door was effectively closed on psychedelic research in 1971 when Congress passed the Controlled Substances Act, which stated that psilocybin, LSD and later MDMA had “” no currently accepted medical uses and a high potential for abuse.

“It was highly unlikely that the researchers received the necessary federal approvals to pursue such studies,” Schmitt told us, “And in this climate, given the cultural and political backlash, there was little will to do so. “

This head-in-the-sand approach to psychedelic research has gone on for decades.

Source link

]]> 0
Ketamine monotherapy reduces suicidal ideation in adults with depression Thu, 16 Sep 2021 20:04:59 +0000

September 16, 2021

2 minutes to read

Source / Disclosures

Disclosures: Di Vincenzo does not report any relevant financial information. Please see the study for relevant financial information from all other authors.

We have not been able to process your request. Please try again later. If you continue to experience this problem, please contact

In adults with treatment-resistant depression, ketamine monotherapy significantly reduced suicidal ideation compared to adjunct ketamine, according to a retrospective study conducted in Journal of Psychiatric Rresearch.

“Ketamine has been almost exclusively studied as an add-on antidepressant to other antidepressants, most often monoaminergic agents such as SSRIs,” Joshua D. Di Vincenzo, the University of Toronto University Health Network and the Brain and Cognition Discovery Foundation and the Canadian Center of Excellence for Rapid Treatment (CRTCE), and colleagues wrote. “Due to the lack of high-quality clinical data on the safety and efficacy of ketamine as antidepressant monotherapy, the majority of clinicians continue to prescribe ketamine to patients as long as they remain on a stable dose of one or more antidepressants for the duration of treatment.

Researchers analyzed data from 220 adults with treatment-resistant depression (TRD) who received four to six IV ketamine infusions for major depressive disorder at CRTCE between August 2018 and May 2021.

They classified 39 participants (17.7%) not currently using other antidepressants, except psychostimulants and sedatives, as the monotherapy group and 181 participants (82.3%) using at least one other antidepressant. as a backup group.

Participants reported thoughts of suicide and the overall severity of depressive symptoms at baseline and after four infusions; anxiety and functional impairment were reported at baseline for 10 patients, after the third infusion for seven and after the fourth for seven others. If Rapid inventory of depressive symptoms – Self-report 16 items (QIDS-SR16) scores for overall symptoms did not improve after two infusions, the dosage was reduced from 0.5 mg / kg of actual body weight to 0.75 mg / kg. This has mainly happened in younger patients.

The monotherapy group had a significantly greater reduction in their mean QIDS-SR16 sub-score for SI (0.91 point, SD = 0.9) than the adjunct therapy group (0.37 point, SD = 0.8). There was no significant difference in improvement between the monotherapy and the add-on groups for anxiety, functional disorders or general depressive symptoms.

“It is important to note that the reference QIDS-SR16 The SI sub-scores were significantly higher in the monotherapy group, therefore a greater decrease on the QIDS-SR16 One can expect an SI in this group compared to the booster group, ”noted Di Vincenzo and his colleagues.

In both groups, ketamine infusion had a strong and significant effect on overall depressive symptoms and anxiety, and a significant average effect on suicidal ideation and functional disturbances.

Limitations included retrospective design, no controls, use of a TRD population, and incomplete data due to dropouts and participants not completing assessments. Di Vincenzo and colleagues have indicated that larger study populations are needed and suggested characterizing patients who will benefit from monotherapy.

“Future research should focus on determining which patients are more likely (or less likely) to benefit from combination therapy versus monotherapy in people with MDD,” they wrote. In addition, whether a specific combination of ketamine and monoaminergic-based antidepressant is optimal also awaits empirical confirmation.

Source link

]]> 0
Depression, anxiety associated with osteocalcin, cortisol in hyperparathyroidism Thu, 16 Sep 2021 15:30:00 +0000

Serum cortisol and osteocalcin levels may be associated with symptoms of anxiety and depression in patients with primary hyperparathyroidism, according to research results published in Frontiers in endocrinology.

To date, the relationships between changes in cortisol and osteocalcin concentrations in primary hyperparathyroidism, as well as their relationships and psychological characteristics in this patient population, have not been evaluated. To solve this problem, the researchers analyzed the potential interaction between these hormones and emotional health.

Psychological questionnaires were administered between August 2020 and December 2020 and obtained for 38 of the 52 patients. Between 2011 and 2020, 192 patients – including 38 with completed questionnaires – were retrospectively assessed. Patients who met the inclusion criteria were included in the present study.

Read on

Because only 38 patients received a psychological assessment, the researchers performed a sensitivity analysis between patients who took these tests and those who did not. The results indicated that there was no difference between the groups in terms of age, sex, duration of illness, weight or height, body mass index (BMI), systolic blood pressure, heart rate, bone mineral density (BMD), serum parathyroid hormone (PTH) concentration, vitamin D, albumin, glycated hemoglobin and phosphorus. Serum calcium concentration, however, was higher in these patients.

Short Form Survey (SF-36) mental component scores were 74.04 ± 23.32 for social function, 72.74 ± 18.71 for mental health, 57.76 ± 22.17 for vitality and 66.67 (range, 0-100) for the role of emotion. The State-Trait Anxiety Inventory-State (STAI-S) score was 35.43 ± 11.56, the STAI-Trait (T) score was 37.39 ± 10.34, and the Beck Depression Inventory (BDI) score was 5 (range, 0-46). Of the 38 patients who completed the questionnaires, 50% with a STAI-S score of 32.2 or higher were in a state of anxiety, while 60.5% of those with a STAI-T score of 31.8 or more have developed anxiety.

The researchers also assessed the association between serum concentrations of PTH, calcium, osteocalcin and cortisol with psychological performance. Results from a bivariate model indicated that cortisol concentration at 8:00 a.m. was “significantly and negatively correlated” with social function. Serum osteocalcin concentration was also significantly and negatively correlated with BDI, while serum PTH and calcium were not correlated with any questionnaire score. After controlling for age, sex and duration of illness, the correlation of cortisol remained true.

Further adjustments for PTH, vitamin D, phosphorus, and calcium showed a significant and continuing negative correlation with 8:00 a.m. cortisol and social function score.

The researchers found that osteocalcin was associated with PTH and was marginally associated with calcium; cortisol was not associated with any of these parameters.

Further testing was done to see if the results could be reproduced in a larger sample size. The researchers evaluated the relationships between osteocalcin, cortisol, PTH and calcium in a group of 192 patients with primary hyperparathyroidism. The mean age of this cohort was 52.7 ± 13.8 years; 76.6% were women.

The results indicated that in terms of bone biochemical markers, serum concentrations of calcium, type I procollagen amino-terminal peptide (PINP) and collagen I-b-telopeptide (b-CTX) were all increased, while that phosphorus was significantly decreased. The percentage of patients in the upper tertile of osteocalcin concentration also increased with an increase in PTH concentration, while serum vitamin D and BMD levels each decreased significantly.

When grouping patients by serum tertile calcium concentration, serum PTH, PINP, b-CTX and the percentages of patients with osteocalcin concentration in the upper tertile were all significantly increased, while serum phosphorus and BMD were significantly reduced.

The results of a bivariate correlation model between serum PTH, osteocalcin and cortisol concentration showed that serum PTH was both positively and significantly correlated with serum osteocalcin; after controlling for age, sex and disease duration, the correlation of PTH with serum osteocalcin concentration was still positive and significant.

Limitations of the study included lack of comparison between postoperative and preoperative serum concentrations and psychological questionnaires, small sample size, potential for selection bias, and a lack of measurement of body water distribution. in patients treated with fluid repletion.

“In this study, it was shown that serum levels of [osteocalcin] and cortisol have been independently associated with the development of psychological symptoms in [patients with primary hyperparathyroidism]”, the researchers concluded.” More basic and clinical studies are needed to test and verify this observation. “


Wang SM, He Y, Zhu MT et al. Associations of serum osteocalcin and cortisol levels with psychological performance in patients with primary hyperparathyroidism. Endocrinol before. 2021; 12: 692722. doi: 10.3389 / fendo.2021.692722

Source link

]]> 0
Many teens struggle with anxiety and depression related to COVID-19. Which therapy is the best? Wed, 15 Sep 2021 10:06:11 +0000

Have you seen it before? We see all the headlines: 100,000 new COVID-19 infections per day … New infections are back to winter levels …

Everyone experiences stress, fear and anxiety, including our young people. The CDC has reported that since the pandemic, visits to pediatric emergency rooms for mental health reasons have increased across the country.

Some of our young patients are stressed that they will be infected and fear taking it home to their parents and grandparents, especially when they go back to school. Some refuse to leave their homes and have chosen distance education for another year. Overwhelming worry and fear that interferes with daily life are symptoms of an anxiety disorder. As specialists in adolescent medicine, we are seeing an increase in anxiety disorders, including generalized anxiety disorder, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD).

PTSD results from exposure to trauma and involves persistent distress or fear, avoidance of things that remind them of the trauma, and mood swings. PTSD can result from watching someone die of COVID-19, or simply from experiencing the pandemic. People with OCD have persistent intrusive and unwanted thoughts, such as believing that they have or will get COVID.

Some teens can’t sleep, feel sad all the time, and stay in their rooms. One patient told us, “I quit the cross country team. … I am no longer in contact with my friends. This is not a normal teenage mood; it’s depression.

In adolescence, the body of adolescents changes and body image develops. Many gained excessive weight during the pandemic as sports were interrupted and they spent more time indoors. At the Nemours Eating Disorder Assessment and Management Program, one patient told us, “I felt really great. … I started to exercise, then I started to skip meals, then I started to purge. Nationally, eating disorders have become more prevalent during the pandemic, and phone calls to the National Eating Disorders Association have increased 70% to 80% from pre-pandemic levels.

You may not know these teens, but you may know others who are suffering, and maybe one is yours. Another heartbreaking concern: We have seen an increase in suicide attempts this year.

Mental health issues are real, not something teens can “get over”. An essential part of improvement is psychotherapy. Therapy can help teens understand their problems, solve problems, change their behaviors, and make positive changes in their lives. There are many types of scientifically supported psychotherapy that involve different approaches. Here are some options:

Cognitive Behavioral Therapy (CBT) combines cognitive and behavioral therapies and has been shown to be the most effective treatment for children and adolescents with anxiety and depression. People with these problems often have distorted thought patterns that lead to distress and dysfunctional behaviors. CBT attacks those self-defeating thought patterns that have become automatic; it helps patients correct and reframe these thoughts. In addition, CBT helps people learn to manage the symptoms of their disease and teaches relaxation techniques.

Dialectical Behavior Therapy (DBT) is often used to treat older teens who have chronic suicidal thoughts and hurt themselves. DBT helps examine how they deal with conflict and intense negative emotions and helps them develop coping skills through mindfulness and emotional regulation. DBT often involves a combination of group and individual sessions.

Family therapy (FBT) is a specific type of family therapy and is considered the gold standard in the treatment of anorexia and bulimia nervosa. FBT is based on the understanding that eating disorders take precedence over the thoughts and behaviors of adolescents and prevent them from making rational, healthy decisions about food, exercise, and their bodies. FBT allows parents to take an active role in helping their teens gain weight, externalize the disorder and normalize their eating habits. FBT is divided into three phases aimed at gradually returning control to adolescents.

Interpersonal therapy (IPT) is a brief, diagnostic-targeted treatment used to help people with depression and other psychiatric disorders. IPT focuses on how interpersonal relationships affect a person’s emotional state and address problematic relationships. IPT helps patients resolve interpersonal crises and identify their social supports to improve their symptoms and their lives.

Our tip: If you notice any changes in your teens’ mood, start by discussing these changes with their primary care provider. Sometimes psychotherapy and medication are needed. Therapy is a process; over time, it can reduce symptoms, provide insight, and improve quality of life.

Rima Himelstein is a specialist in adolescent medicine and Bailey DeLong is a master’s level social worker at the Children’s Hospital in Nemours, Delaware.

Source link

]]> 0
Parents Worried About Their Son’s Depression | Lifestyles Sat, 11 Sep 2021 04:00:00 +0000

DR. WALLACE: We love our son very much and want to support him in every way, and he seems to be very depressed lately. When we asked about it, he told us he was unsure of its value to society. He sort of seems to think that nothing he does is good enough and nothing matters because he can’t change the world on his own.

Our family love him and hate to see him suffer for any reason; we would like to help him.

Our son is a good student and an exceptional athlete. Is there an organization or group that our family can contact as a starting point to see what professional help may be available? – Concerned mother, by e-mail

MOTHER CONCERNED: Yes, there are many services available for you and your family. Immediately talk to other parents, family and friends to see what experiences they may have had with depressed people in their lives. Your close circle of friends and family can often be supportive and recommend a variety of local resources that could be of great value to your son and family.

I also know of a national organization that you can contact immediately to gather information and possibly get local references. Go to SAMHSA (Substance Abuse and Mental Health Services Administration) at this web address:

The SAMHSA National Helpline is a free, confidential, 24/7/365 treatment referral and information service (in English and Spanish) for individuals and families facing mental health and / or addiction issues.

This service provides referrals to local treatment facilities, support groups and community organizations. Callers can also order free publications and other information.

It is a government agency and its referral service is free for those who request it. Their national helpline is (800) 662-HELP (800 662-4357.)

For people without insurance or underinsured, this organization will direct you to your state office, which is responsible for state-funded treatment programs. In addition, they can often direct you to establishments that charge tapering rates or accept Medicare or Medicaid. For those with health insurance, we encourage you to contact your insurer for a list of participating health care providers and facilities.

The services provided are confidential and no personal information will be requested. This helpline is staffed with trained specialists who answer calls, transfer callers to public services or other appropriate drop-in centers in their states, and connect them to local assistance and support.

Thanks for proactively writing to us here. My team and I recommend that you get in touch with this organization immediately and research any other leads that you can collect locally from your family and friends. Mental health issues like depression should be taken very seriously and addressed directly as quickly as possible. We wish you success on your journey to help your son and your family.

TEENS: On this day, Americans witnessed the best and the worst of humanity 20 years ago in New York, Washington, DC and Shanksville, Pennsylvania. Every teenager alive today was not yet born when the sun went down on that terrible day.

I encourage all of you to remember and honor the many fallen first responders and law enforcement heroes who have faced great danger, as well as the compassionate ordinary citizens and their families who have helped each other on this day. fateful and throughout the two decades that followed.

Source link

]]> 0
Our patients are resilient | MedPage today Wed, 08 Sep 2021 00:01:31 +0000

Patient name and other descriptors have been changed to protect confidentiality.

Sara is a 14 year old patient of mine. I am a clinical psychologist and have been treating her for about 15 months. Sara has struggled with trauma and associated psychiatric symptoms since the coronavirus ravaged her family.

This is the story of Sara’s treatment. What is so remarkable about her is her plight and her journey to recovery. And informative. And worthy to be shared.

Sara is a bright and social young teenager who navigated her day to day life. She had a happy and satisfied family with her parents and three siblings. She was a good student, had many friends and loved to ride horses. She was starting to show an interest in dating. And she loved going to high school and college football games.

Then the coronavirus pandemic struck. His world has been turned upside down. It was a traumatic time for her because her father was infected with COVID-19. He was extremely ill, requiring hospitalization and ventilation. After 12 grueling days in the hospital, Sara’s father passed away.

Sara was devastated by the death of her father. It didn’t make sense to her. She was riddled with powerful and endless questions: How could a virus kill her father when we live in the largest country on the planet? How could he not be saved? Did she do something wrong? How are we going to do it as a family? How can I help my mother?

Around the same time that losing her father, Sara’s school stopped in-person classes. He missed his friends and favorite teachers. Staying at home was a constant reminder of her father’s absence. But she was able to keep a watchful eye on her mother and siblings as they all struggled with their collective pain and grief.

Sara was clearly getting depressed. She was sad. She cried. She was tense. She worried constantly. She was afraid. She had trouble sleeping at night. His happy, joyous mind was now stifled. She wasn’t smiling or laughing. She was preoccupied with negative and morbid thoughts. She was cranky and catchy with her siblings. She has stopped talking to her friends on the phone or by text. She lost 15 pounds unintentionally.

Sara was brought to see me by her mother. Her mother herself was lost in sadness but could see that her daughter was struggling mightily. She feared that Sara would become more and more depressed and discouraged. She was afraid of being suicidal.

To her credit, Sara was eager for professional help. She and I connected immediately and our therapeutic alliance blossomed. We both knew she was deeply depressed by the sudden death of her father and the unintended daily consequences of this pandemic. I was worried about Sara, but I also knew that her excellent premorbid mental health meant that she had a very positive prognosis for recovery. But it would be a difficult road to travel.

I referred Sara to her pediatrician for antidepressant medication as her depression was so severe and it was affecting her sleep and appetite. She tolerated the medication well and it helped. She was grateful for it.

Psychotherapy with Sara progressed extremely well until she had to deal with yet another staggering trauma – her mother fell ill with COVID-19.

Sara decompensated with the news of her mother’s illness. Her depression flourished again when her mother was hospitalized due to the severity of her illness. Sara and her siblings went to live with her aunt, uncle and cousins ​​while her mother was in the hospital. She thought it would be a short-term sleep arrangement until her mother came home.

But it was not.

Sara’s mother died of COVID-19 at the same hospital where her father died. Sara has been destroyed. She was consumed with fear. She felt lost and alone. She couldn’t stop crying.

Fortunately, Sara and her siblings were welcome to stay with her aunt and uncle. This stability was such a blessing to them. And Sara continued to see me in weekly therapy sessions. Her therapy had become a major anchor for her. She knew this was the place where all of her feelings and fears could be verbalized, understood and contained. By content, I mean she was able to sense her feelings and process them so that they didn’t overwhelm her in her daily life.

Sara was afraid of losing me too because of the coronavirus. It was a “transfer reaction” to the two deaths she had faced. His fears about me opened a new door to exploration. Even as a young teenager, she could understand that her dependence on me was due to the unexpected death of her parents. It also affirmed that we did indeed have a therapeutic alliance that allowed for honest and open communication about all of her feelings. It was psychotherapy at work.

Sara grapples with a mixture of intense feelings: sadness, fear, loneliness, guilt, a sense of responsibility and many more. All of this is water for the mill in its ongoing therapy.

Sara continues to see me every week. She’s weathered the storm of trauma and is recovering. She is still on medication, which helps her strengthen her defenses and shine her natural positivity and optimism. She feels in control of her life. She did not become a victim of her trauma but rather a proactive and healthy master of her emotional life.

The pandemic has created havoc and indescribable angst. He was underestimated by so many people. His victims have experienced traumas that will change the course of their lives. Ask Sara.

Sara’s recovery is a process, but it is palpable. We can feel it and we can see it. Psychotherapy and medication – alone or in combination – can make a demonstrable difference.

It is the resilience and recovery of patients like Sara that motivates me to do my job every day in the face of this dreadful pandemic. We all have to endure.

Alan D. Blotcky, PhD, is a clinical psychologist in private practice in Birmingham, Alabama.

Source link

]]> 0
rains from Fred force closure of Asheville water source | North Carolina News Fri, 03 Sep 2021 21:35:00 +0000

ASHEVILLE, North Carolina (AP) – Precipitation from the remnants of Tropical Depression Fred last month forced a city in North Carolina to shut down a reservoir and water treatment plant due to what a responsible calls it “bad water conditions”.

The rains swelled the streams that feed a lake that serves as the region’s main source of drinking water, the Asheville Citizen Times reported on Friday. Asheville Water Resources Director David Melton said cloudy water in the Bee Tree Reservoir increased dramatically on August 17, also leading to the shutdown of the William DeBruhl water treatment plant.

The water service was not affected due to the large capacity of other sources, including the much larger North Fork Reservoir, Melton said, adding that he hoped the reopening of Bee Tree and the water treatment plant would take place “within the next two weeks”.

The water service was not affected due to the large capacity of other sources, including the much larger North Fork reservoir, he said.

Bee Tree Reservoir at Swannanoa is the smaller of two lakes in eastern Buncombe County that supplies Asheville with drinking water.

Political cartoons

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Source link

]]> 0
Watch Out For The Warning Signs Of Depression Health Wed, 01 Sep 2021 03:15:00 +0000

Childhood is often seen as a happy time without worries or responsibilities. As we take a closer look at our childhoods or that of others, we recognize that being “blue”, feeling sad, worried or anxious are everyday emotions that children go through as they develop.

A recent review by Dr. J. Casarella with WebMD deals with depression in childhood. She notes that just because a child seems sad doesn’t necessarily mean depressed. However, if this sadness becomes persistent or interferes with normal social activities, interests, schoolwork, or family life, it may mean that they are suffering from a depressive illness.

Sometimes depression seems to come out of nowhere and other times when children are stressed or grieving. Bullying and spending a lot of time on social media can be associated with depression. Depression has also been linked to other problems such as attention problems, learning problems, behavioral problems or anxiety disorders.

It is important to understand that depression is not caused by one thing, but possibly by a combination of factors interacting with each other. The two factors can be grouped into two broad categories: biology and psychology. Biological factors include genes, hormones, and chemicals in the brain.

Genetic factors are suggested because depression is often familial. However, a person can inherit the gene that makes them vulnerable but never have the disease. Hormonal changes occur during depression.

The brain undergoes some changes before and during the depressive episode. Certain parts of the brain are affected, causing certain hormones to be over / underproduced. Drugs can be effective in the treatment.

Neurotransmitters are chemicals that help nerve cells communicate. It is believed that during depression the activity of one or more of these chemicals is reduced. Many antidepressants increase neurotransmitters in the brain.

The main symptoms of depression, which are similar in children and adults, are sadness or bad mood, feelings of hopelessness, and mood swings. Young children may have a depressed mood and take action or behave in anger.

Some of the signs and symptoms of depression in children include bad mood; social withdrawal; more or less appetite or sleep; tears; tired; physical problems (upset stomach and headache); decreased interest in activities at home, at school, with friends; impaired thinking and concentration; and most importantly, thoughts of death or suicide.

The lifetime prevalence of major depressive disorder among 13-18 year olds in the United States is 11% (about 1 in 10), and about 7% of depressed teens attempt suicide. Suicide deaths in the 15-24 age group are around 5,000 per year and rates during the pandemic crisis are increasing.

Call 911 immediately if you tried to kill yourself today, if your child is confused, or if you think it is a life-threatening emergency. Go to the emergency room if there are threats of suicide or if they have a suicidal plan or thoughts. Call your doctor right away if your child cannot calm down or is severely depressed.

The National Suicide Hotline is 800-273-8255. The local Teen Health Center is also a mental health resource.

Sally robinson is a clinical professor of pediatrics at the UTMB children’s hospital. This column is not intended to replace the advice of your child’s doctor.

Source link

]]> 0